Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Biogen (NASDAQ:BIIB) reported stronger-than-expected second-quarter results on Wednesday, with revenue and adjusted earnings exceeding Wall Street forecasts as its expanding portfolio of growth products continued to offset weakness in its legacy multiple sclerosis business. The biotechnology company posted revenue of $2.
Biotech company Biogen (NASDAQ:BIIB) announced better-than-expected revenue in Q2 CY2026, with sales up 3.4% year on year to $2.74 billion. Its non-GAAP profit of $3.60 per share was 75.8% above analysts’ consensus estimates.
Electrical connector manufacturer Amphenol (NYSE:APH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 55% year on year to $8.76 billion. On top of that, next quarter’s revenue guidance ($9.35 billion at the midpoint) was surprisingly good and 7.1% above what analysts were expecting. Its non-GAAP profit of $1.35 per share was 13.2% above analysts’ consensus estimates.
Archer Aviation has gone from retail darling to distressed asset trading near multi-year lows, and a short list of corporate giants already has the motive, money, and strategic logic to make a move before someone else does.
Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.
Seagate Technology PLC (NASDAQ:STX) shares gained nearly 3% in pre-market trading on Wednesday after the data storage company reported stronger-than-expected fourth-quarter earnings and revenue while issuing first-quarter guidance that significantly exceeded Wall Street forecasts. The company reported adjusted earnings of $5.
Earlier this month, Zacks Equity Research highlighted Sezzle Inc. as an attractive growth-focused payments company, citing a strong Growth Score, a top Zacks Rank, and expectations for earnings per share expansion that outpaces its diversified financials peers. The report also pointed to fast-growing cash flows and recent upward revisions to earnings estimates as key supports for Sezzle’s earnings outlook. Next, we’ll examine how Sezzle’s upgraded earnings estimates and growth profile could...
Oklo (NYSE:OKLO) received startup authorization from the U.S. Department of Energy for its Groves Isotope Test Reactor. The approval completes a key regulatory process and allows Oklo to begin fuel loading, startup testing, and reactor operations. Oklo focuses on advanced nuclear reactors and related services, with the Groves Isotope Test Reactor positioned to support production of high value isotopes for multiple industries. For investors watching the nuclear space, this milestone...
Visa (NYSE:V) reported stronger-than-expected fiscal third-quarter results on Tuesday, with double-digit revenue growth supported by resilient consumer spending and continued strength in cross-border payment activity. The global payments company posted adjusted earnings of $3.
FDA calendars are stacking up fast, obesity Phase 3 data is closing in, and three biotech names spanning the risk spectrum are quietly positioning for a pivotal back half of 2026.
Amazon reported its Q2 earnings after the bell on Thursday.
Apple reported its Q3 earnings on Thursday.
Energy Transfer continues to grow its already lucrative income stream.
Generac Holdings (GNRC) delivered earnings and revenue surprises of +49.23% and -0.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Goldman Sachs reiterated its ‘Buy’ rating and $465 price target, saying the results and outlook support further upside for the stock.
Investing.com -- Shares in Boston Scientific rose over 3% in premarket trading Wednesday after the medical device maker reported second-quarter earnings and revenue that topped Wall Street estimates.
July 29 () - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U. Shares of the medical device maker rose 12% in premarket trading.
July 29 (Reuters) - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed
Two rules-based ETFs have both outrun the S&P 500, yet they are built on completely opposite bets, and the same market conditions that reward one will likely punish the other.
Building operations company Johnson Controls (NYSE:JCI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.3% year on year to $6.61 billion. Its non-GAAP profit of $1.42 per share was 9% above analysts’ consensus estimates.
Vertiv (VRT) delivered earnings and revenue surprises of +6.29% and -3.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
After an early pop following its record initial public offering, SpaceX shares have struggled.
RWR offers broader diversification, while XLRE's more concentrated portfolio charges lower fees.
This company benefits during periods of heightened volatility in the stock market.
Investing.com -- Biogen reported second-quarter revenue and adjusted profit above analysts’ estimates on Wednesday, helped by 24% growth in its Growth Portfolio and stronger revenue from recently acquired products, although sales of its Alzheimer’s drug Leqembi narrowly missed expectations.
Ford Motor Company (NYSE:F) shares climbed more than 4% after the automaker reported better-than-expected second-quarter results and raised its financial outlook for the full year, supported by stronger operating performance across its core business. The company posted adjusted earnings per share of $0.
Investing.com -- Shares in Vertiv tumbled more than 9% in premarket trading Wednesday even as the data center equipment maker reported second-quarter earnings above estimates and raised its full-year guidance, with a revenue shortfall offseting the beat.
‘There won’t be anything that AI can’t do better than humans.’
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
